Myoepithelial Tumor
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) (NCT05266196) | Salarius Pharmaceuticals, LLC | 2022-01-15 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (NCT03600649) | Salarius Pharmaceuticals, LLC | 2018-06-04 |
Track Myoepithelial Tumor automatically
Every clearance here is in the API, with alerts when new ones post.